Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

McGill University

$166,500.00

Rapid detection of MRSA and identification of strain using an autonomous microfluidic chip with bacteriophages

FY 2012-13

Summary
BACKGROUND: Bacterial infections and in particular nosocomial - hospital-acquired - infections, are a growing problem in worldwide, especially from bacteria resistant to antibiotics, so called ""superbugs"". A recent study identified that more than 51% of intensive care unit patients are infected, and in Canada more people will die from hospital acquired infections than from AIDS, car accidents and breast cancer combined, incurring costs of at least $100 million annually to the Canadian healthcare systems. Methicillin-resistant Staphylococcus aureus (MRSA) is among the most common bacteria found in hospitals causing manty infections and death. The control of the spread of bacteria to multiple patients in hospitals and the efficacy of treatment will depend on early detection of bacteria. There is an urgent need to rapidly detect and diagnose SA infection, to identify whether it is an MRSA strain, and monitor mutations and the appearance of new strains to help adjust patient therapy. OBJECTIVE: We propose to develop a self-powered microfluidic platform that is simple to operate, compatible with common clinic laboratories, and can be read out using a simple CCD camera for (i) the rapid detection of MRSA in 30 min to triage patients and isolate the infected ones. The chip will be able to identify what particular strain of bacteria has infected the patient, and to take suitable action.
Program
Collaborative Health Research Projects
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
398748-2011
Name nom
Juncker, David
Department département
Biomedical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
166500
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
2
Nb partie
3
Application title
Rapid detection of MRSA and identification of strain using an autonomous microfluidic chip with bacteriophages
Keyword
NSERC
Application summary
BACKGROUND: Bacterial infections and in particular nosocomial - hospital-acquired - infections, are a growing problem in worldwide, especially from bacteria resistant to antibiotics, so called ""superbugs"". A recent study identified that more than 51% of intensive care unit patients are infected, and in Canada more people will die from hospital acquired infections than from AIDS, car accidents and breast cancer combined, incurring costs of at least $100 million annually to the Canadian healthcare systems. Methicillin-resistant Staphylococcus aureus (MRSA) is among the most common bacteria found in hospitals causing manty infections and death. The control of the spread of bacteria to multiple patients in hospitals and the efficacy of treatment will depend on early detection of bacteria. There is an urgent need to rapidly detect and diagnose SA infection, to identify whether it is an MRSA strain, and monitor mutations and the appearance of new strains to help adjust patient therapy. OBJECTIVE: We propose to develop a self-powered microfluidic platform that is simple to operate, compatible with common clinic laboratories, and can be read out using a simple CCD camera for (i) the rapid detection of MRSA in 30 min to triage patients and isolate the infected ones. The chip will be able to identify what particular strain of bacteria has infected the patient, and to take suitable action.